1. Home
  2. DRTS vs DFIN Comparison

DRTS vs DFIN Comparison

Compare DRTS & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$13.34

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$67.49

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
DFIN
Founded
2015
1983
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
DRTS
DFIN
Price
$13.34
$67.49
Analyst Decision
Buy
Buy
Analyst Count
5
3
Target Price
$17.80
★ $75.33
AVG Volume (30 Days)
★ 471.5K
305.9K
Earning Date
11-19-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 3.58
Revenue
N/A
★ $963,000,000.00
Revenue This Year
N/A
$3.19
Revenue Next Year
$1,235.59
$4.12
P/E Ratio
★ N/A
$19.44
Revenue Growth
★ N/A
N/A
52 Week Low
$3.43
$36.11
52 Week High
$15.79
$72.04

Technical Indicators

Market Signals
Indicator
DRTS
DFIN
Relative Strength Index (RSI) 54.48 84.03
Support Level $13.73 $46.15
Resistance Level $15.23 N/A
Average True Range (ATR) 0.66 2.45
MACD 0.10 1.75
Stochastic Oscillator 92.31 88.56

Price Performance

Historical Comparison
DRTS
DFIN

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance software solutions and related services provider. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. It operates in four reportable segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management (its key revenue-generating segment), Investment Companies - Software Solutions, and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States (USA), Europe, Asia, Canada, and Others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: